David E. Carpenter, Contributor

Author's posts

Australia The First Nation To Approve The Legal Use Of MDMA And Psilocybin

Psychedelic drugs are at last being recognized by governments around the world as potentially life-saving medicines.

As Use Of The World’s Most Potent Psychedelic Skyrockets, New Site F.I.V.E. Fills An Education Void

This is your brain educated on drugs.

Film ‘DOSED 2’ Explores Legal Psychedelic Therapy, Highlights The Changing Landscape Of Mental Health Care

DOSED 2: The Trip of a Lifetime

Sydney Researchers Awarded Over $2.2 Million By Australian Government To Study MDMA, Psilocybin

Government funding shows political support for psychedelic research in Australia.

Nurses In Psychedelics, Naturals Caring For Patients In Non-Ordinary States Of Consciousness

Nurses are skilled in holding space as patients endure challenging events in real time and for prolonged periods, whether during childbirth, a sudden illness or the time surrounding death

Psychedelic Therapy Is Poised To Create A Revolution In Mental Health, Can VR Accelerate It?

VR looks to cover the unmet need of assisting people unfamiliar with the use of psychedelics in clinical settings.

Researchers In Europe, U.S. Team Up To Produce First Ever 5-MeO-DMT Psychedelic Training Program

The psychedelic land rush is on. And with it comes the necessary machinery that mental health clinicians will utilize to help treat patients.

As More People Turn To Psychedelics, Integration Proves A Crucial Factor For Breakthroughs

While psychedelic treatments aren’t a cure switch, they do offer a great window of opportunity to heal.

Four Terminally Ill Canadians Gain Legal Right To Use Magic Mushrooms For End-Of-Life Distress

A large leap forward for compassionate care using psilocybin therapy.

Psychedelic Pioneer Rick Doblin On FDA Trials Of MDMA: Most Important Reality Check Of MAPS’ 34-Year History

“In the pharmaceutical drug development community, this is what you dream about,” says Doblin.